Gene therapy: Regulatory issues and international approaches to regulation

被引：7

作者：

CohenHaguenauer, O

机构：

[1] Lab. Transfert Genet. Oncol. Molec., Institut d'Hématologie, 75475 Paris Cedex 10

来源：

CURRENT OPINION IN BIOTECHNOLOGY | 1997年 / 8卷 / 03期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1016/S0958-1669(97)80018-3

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：361 / 369

页数：9

共 17 条

[1] Safety and regulation at the leading edge of biomedical biotechnology [J].

CohenHaguenauer, O .

CURRENT OPINION IN BIOTECHNOLOGY, 1996, 7 (03) :265-272

[2] OVERVIEW OF REGULATION OF GENE-THERAPY IN EUROPE - A CURRENT STATEMENT INCLUDING REFERENCE TO US REGULATION [J].

COHENHAGUENAUER, O .

HUMAN GENE THERAPY, 1995, 6 (06) :773-785

[3]

COHENHAGUENAUER O, 1996, SCRIP ICH3 INT C HAR, P8

[4]

*DEP EV PROD BIOL, 1996, FICH RENS ESS CLIN T

[5]

*HLTH SCI COUNC JA, 1993, GUID GEN THER CLIN R

[6]

KNAZEK RA, 1996, FORUM 1996 GENE THER, P41

[7]

LINDEMANN A, 1995, J MOL MED-JMM, V73, P207

[8]

MARTIN P, 1996, 5 U SUSS ERSC CTR SC

[9] In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector [J].

Naldini, L ;

Blomer, U ;

Gallay, P ;

Ory, D ;

Mulligan, R ;

Gage, FH ;

Verma, IM ;

Trono, D .

SCIENCE, 1996, 272 (5259) :263-267

[10]

*NIH, 1990, HUM GENE THER, V1, P93

← 1 2 →